Northwestern University — Cancer Nanotechnology Training Program

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Northwestern University

Principal Investigator: Gayle Woloschak, Ph.D.

Training Focus and Objectives

The goal of this program is to train MD- and PhD-level investigators (up to 4 per year) in the principles and tools of nanotechnology, cancer biology, and clinical oncology with the eventual goal of applying these skills to translational research that impacts cancer patients. The training program offers a well-rounded curriculum with basic courses, career development programs, and research-based experiences that is designed around the needs of each of the trainees. Training includes many nanotechnology resources including NU's International Institute for Nanotechnology, the Institute for BioNanotechnology, and the NU CCNE. Faculty from each of these centers participate in our T32 program. Fellows enrolled in the training program will acquire the skills and knowledge to design cancer nanomaterials, to investigate their biological properties, and to evaluate their safety and efficacy.

Visit the Northwestern CNTC website.

  • Posted: August 8, 2017

Most text on the National Cancer Institute website may be reproduced or reused freely. The National Cancer Institute should be credited as the source. Please note that blog posts that are written by individuals from outside the government may be owned by the writer, and graphics may be owned by their creator. In such cases, it is necessary to contact the writer, artist, or publisher to obtain permission for reuse.

We welcome your comments on this post. All comments must follow our comment policy.